Endogenous 211At alpha-particle radiotherapy for undifferentiated thyroid cancer.
Brown
I
I
Research Laboratories, Cambridge University School of Clinical Medicine, England.
Carpenter
R N
RN
D000230:Adenocarcinoma / Q000532:radiotherapy*; D000512:Alpha Particles; D000818:Animals; D001246:Astatine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D013964:Thyroid Neoplasms / Q000532:radiotherapy*; D014018:Tissue Distribution; D014183:Transplantation, Heterologous
D001246:Astatine